The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension (Q39003465)

8 September 2017

1 reference

title

The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension (English)

1 reference

8 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27826710 AND SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Yasunobu Hayabuchi

series ordinal

1

1 reference

8 September 2017

publication date

8 November 2016

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27826710 AND SRC:MED&resulttype=core&format=json

4 June 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27826710 AND SRC:MED&resulttype=core&format=json

4 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27826710 AND SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27826710 AND SRC:MED&resulttype=core&format=json

Definitions and diagnosis of pulmonary hypertension.

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

New guidelines for managing pulmonary hypertension: what the pediatrician needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

The Pulmonary Hypertension Consult: Clinical and Coding Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Update in treatment options in pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Development and pathology of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Pathology and pathobiology of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Pathobiology of pulmonary hypertension. Extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Pathology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Genetic analyses in a cohort of children with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Genetic Insights into Pulmonary Arterial Hypertension. Application of Whole-Exome Sequencing to the Study of Pathogenic Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Genetics of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

A novel channelopathy in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Updated Clinical Classification of Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

BMPR2 spruces up the endothelium in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Expression of mutant bone morphogenetic protein receptor II worsens pulmonary hypertension secondary to pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Preferential expression and function of voltage-gated, O2-sensitive K channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Hypoxia inhibits gene expression of voltage-gated K channel alpha subunits in pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Genetics and genomics of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Patho-, physiological roles of voltage-dependent K channels in pulmonary arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Dysregulation of a potassium channel, THIK-1, targeted by caspase-8 accelerates cell shrinkage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Advances in therapeutic interventions for patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Potassium channel diversity in the pulmonary arteries and pulmonary veins: implications for regulation of the pulmonary vasculature in health and during pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Pulmonary hypertension: chapters of innovation and tribulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Insulin-like growth factor-I inhibits rat arterial K(ATP) channels through pI 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Evidence for involvement of A-kinase anchoring protein in activation of rat arterial K(ATP) channels by protein kinase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Iptakalim ameliorates monocrotaline-induced pulmonary arterial hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Iptakalim, a novel ATP-sensitive potassium channel opener, inhibits pulmonary arterial smooth muscle cell proliferation by downregulation of PKC-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Early onset severe pulmonary arterial hypertension with 'two-hit' digenic mutations in both BMPR2 and KCNA5 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Endothelium-derived hyperpolarizing factor activates Ca2 -activated K channels in porcine coronary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Ion channel switching and activation in smooth-muscle cells of occlusive vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Role of ion channels and transporters in cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Cell membrane stretch activates intermediate-conductance Ca2 -activated K channels in arterial smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Activation of K channels: an essential pathway in programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Therapeutic potential of KCa3.1 blockers: recent advances and promising trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00246-016-1491-7

Angiotensin II activates intermediate-conductance Ca2 -activated K channels in arterial smooth muscle cells

21 January 2018

1 reference

12 December 2020

Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.

1 reference

12 December 2020

Angiotensin II inhibits and alters kinetics of voltage-gated K( ) channels of rat arterial smooth muscle

1 reference

12 December 2020

Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation

1 reference

12 December 2020

Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT

1 reference

12 December 2020

K( ) channels: function-structural overview.

1 reference

12 December 2020

10.1007/S00246-016-1491-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27826710 AND SRC:MED&resulttype=core&format=json

4 June 2020

1 reference